소개

이 페이지에서는 Joseph J Larosa의 공개된 내부자의 매매 거래 내역을 종합적으로 분석합니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다. 이러한 제한에도 불구하고, 학계 연구에 따르면 내부자는, 일반적으로, 자신의 회사 주식에 대한 실적이 시장의 수익률을 능가하는 경향성을 보였습니다.

평균 거래 수익성

평균 거래 수익성은 내부자가 지난 3년 동안 매입한 모든 "공개 시장"(Open market)에서의 매입의 평균 수익률입니다. 이를 계산하기 위해 10b5-1 거래 계획의 일부로 표시된 모든 거래를 제외하고 내부자가 계획되지 않은 모든 오픈 마켓에서의 매입을 조사합니다. 그런 다음 3개월, 6개월, 12개월 동안 해당 거래의 평균 성과를 계산하여 각 거래에 대한 최종 성과 지표를 생성합니다. 마지막으로 내부자에 대한 성과 지표를 계산하기 위해 모든 성과 지표의 평균을 내립니다. 이 목록에는 지난 2년 동안 최소 3번 이상 거래한 내부자만 포함됩니다.

내부자의 매매 거래 수익성이 "해당 없음"인 경우, 내부자는 지난 3년 동안 공개 시장에서 매수한 적이 없거나, 거래가 너무 최근에 이루어져서 신뢰할 수 있는 성과 지표를 산출할 수 없는 경우에 해당합니다.

업데이트 주기: 일별

최고 수익율의 내부자 목록을 확인하세요.

내부자 포지션이 보고된 기업

SEC 서류에 따르면 Joseph J Larosa 기업이 다음 기업에 대한 보유 또는 거래를 보고했습니다:

증권 소유권 최근 보고된 보유 주식
US:REGN / Regeneron Pharmaceuticals, Inc. EVP General Counsel and Secret 29,517
차트 해석 방법

아래 차트는 Joseph J Larosa에 의한 각 "공개 시장"(Open market)에서 계획되지 않은 거래 이후 증권의 주가 실적을 보여줍니다. 계획되지 않은 거래는 10b5-1 거래 계획의 일환으로 이루어지지 않은 거래입니다. 주가 실적은 주가의 누적 백분율 변화로 표시됩니다. 예를 들어, 2019년 1월 1일 내부자의 매매 거래가 이루어졌을 경우, 차트는 현재까지 증권의 일별 백분율 변화를 보여줍니다. 이 기간 동안 주가가 10달러에서 15달러로 간다면, 주가의 누적 백분율 변화는 50%가 됩니다. 10달러에서 20달러로의 가격 변화는 100%가 되며, 10달러에서 5달러로의 가격 변화는 -50%가 됩니다.

궁극적으로 내부자의 매매 거래가 내부자의 정보를 이용하여 이익을 얻기 위해 거래 타이밍을 맞추고 있는지 확인하기 위해 내부자의 매매 거래가 주가의 초과 수익률(양 또는 음)과 얼마나 밀접한 상관 관계가 있는지 확인하고자 합니다. 내부자가 이러한 작업을 수행하고 있는 상황을 고려해 보겠습니다. 이러한 상황에서 우리는 (a) 매입 후 양의 수익률 또는 (b) 매각 후 음의 수익률을 기대할 수 있습니다. (a)의 경우, 매입 차트는 상향으로 기울어진 일련의 곡선을 보여주며, 각 매입 거래 후 양의 수익률을 나타냅니다. (b)의 경우, SALE 차트는 하향으로 기울어진 일련의 곡선을 보여주며, 각 판매 거래 후 음의 수익률을 나타냅니다.

그러나 이것만으로는 결론을 도출하기에 충분하지 않습니다. 예를 들어, 해당 기업의 주가가 수년에 걸쳐 비주기적 상승 추세에 있다면, Fintel은 매입 후 도표가 모두 상향 곡선으로 예상할 수 있습니다. 마찬가지로, 수년에 걸쳐 비주기적 하락은 거래 후에 하향 곡선으로 초래할 가능성이 높습니다. 이 도표들 중 어느 것도 내부자의 매매 거래 활동을 시사하지는 않습니다.

가장 강력한 지표는 주가가 극단적으로 순환하는 상황일 것이고, PURCHASE 차트에는 긍정적인 시그널이, SALE 차트에는 부정적인 플롯이 존재했습니다. 이는 자신들의 금전적 이익을 위한 거래 타이밍을 재던 내부자에 의한 상황일 가능성이 높습니다.

내부자의 매매 거래 내역

아래 표는 증권거래위원회(SEC)에 공시된 Joseph J Larosa의 내부자의 전체 거래 목록입니다.

보고일 거래일 보고 티커 증권 코드 10b5-1 지분 잔여 지분 변동률
(%)
지분
가치
거래
가치
잔여
가치
2025-12-09 2025-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,396 29,517 -4.52 712.94 -995,264 21,043,850
2025-12-09 2025-12-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2,476 30,913 8.71
2025-11-24 2025-11-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -12,686 22,839 -35.71 736.77 -9,346,664 16,827,090
2025-11-24 2025-11-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 14,450 35,525 68.56 555.67 8,029,432 19,740,177
2024-12-18 2024-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -702 30,075 -2.28 730.81 -513,029 21,979,111
2024-12-10 2024-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -492 30,777 -1.57 787.00 -387,204 24,221,499
2024-12-10 2024-12-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2,332 31,269 8.06
2024-07-12 2024-07-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,866 37,937 -4.69 1,088.95 -2,031,981 41,311,496
2024-06-25 2024-06-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -11,084 39,803 -21.78 1,060.13 -11,750,481 42,196,354
2024-06-25 2024-06-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 14,450 50,887 39.66 555.67 8,029,432 28,276,379
2024-06-12 2024-06-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -1,608 0 -100.00
2024-05-22 2024-05-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,865 34,678 -5.10 994.90 -1,855,488 34,501,142
2024-02-28 2024-02-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,000 36,543 -2.66 990.00 -990,000 36,177,570
2024-02-26 2024-02-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,000 37,543 -2.59 967.65 -967,650 36,328,484
2024-02-09 2024-02-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,000 38,543 -2.53 950.00 -950,000 36,615,850
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -24,493 39,543 -38.25 912.30 -22,344,964 36,075,079
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 34,000 64,036 113.20 399.66 13,588,440 25,592,628
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -669 30,036 -2.18 844.09 -564,696 25,353,087
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2,133 30,705 7.47
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -852 28,572 -2.90 843.79 -718,909 24,108,768
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6,742 27,471 -19.71 801.59 -5,404,320 22,020,479
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 34,213 41.30 270.43 2,704,300 9,252,222
2023-03-14 2023-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -1,006 0 -100.00
2022-12-20 2022-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2,752 23,110 13.52
2022-12-13 2022-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -492 20,358 -2.36 753.28 -370,614 15,335,274
2022-09-12 2022-09-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -20,730 20,850 -49.86 730.96 -15,152,801 15,240,516
2022-09-12 2022-09-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30,000 41,580 259.07 270.43 8,112,900 11,244,479
2022-04-11 2022-04-07 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,114 16,900 -23.23 721.10 -3,687,705 12,186,590
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15 22,014 -0.07 701.82 -10,527 15,449,865
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 22,029 -0.56 698.26 -86,584 15,381,970
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -64 22,153 -0.29 697.35 -44,630 15,448,395
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -254 22,217 -1.13 696.54 -176,921 15,475,029
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -305 22,471 -1.34 695.36 -212,085 15,625,435
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -259 22,776 -1.12 694.56 -179,891 15,819,299
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -567 23,035 -2.40 693.92 -393,453 15,984,447
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -195 23,602 -0.82 692.54 -135,045 16,345,329
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -641 23,797 -2.62 691.44 -443,213 16,454,198
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -250 24,438 -1.01 690.51 -172,628 16,874,683
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -218 24,688 -0.88 689.43 -150,296 17,020,648
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -799 24,906 -3.11 688.59 -550,183 17,150,023
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -497 25,705 -1.90 687.41 -341,643 17,669,874
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -557 26,202 -2.08 686.26 -382,247 17,981,385
2022-04-04 2022-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -369 26,759 -1.36 685.71 -253,027 18,348,914
2021-12-14 2021-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -697 26,051 -2.61 664.34 -463,045 17,306,721
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -30,000 0 -100.00
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -19,772 26,748 -42.50 657.11 -12,992,379 17,576,378
2021-12-10 2021-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 30,000 46,520 181.60 179.13 5,373,900 8,333,128
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 14,253 14,253
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 3,338 16,520 25.32
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1 13,182 -0.01 666.22 -666 8,782,112
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -41 13,183 -0.31 665.40 -27,281 8,771,968
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,383 13,224 -20.37 661.80 -2,238,869 8,751,643
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -10,000 30,000 -25.00
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -6,575 16,607 -28.36 664.85 -4,371,389 11,041,164
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10,000 23,182 75.86 179.13 1,791,300 4,152,592
2021-07-07 2021-07-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,398 13,182 -20.49 580.00 -1,970,840 7,645,560
2021-07-07 2021-07-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -10,000 40,000 -20.00
2021-07-07 2021-07-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -6,602 16,580 -28.48 582.20 -3,843,684 9,652,876
2021-07-07 2021-07-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10,000 23,182 75.86 179.13 1,791,300 4,152,592
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 19,950 19,950
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1,930 16,368 13.37
2020-08-31 2020-08-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -4,672 14,438 -24.45 615.04 -2,873,467 8,879,948
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -4,000 0 -100.00
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -6,000 4,000 -60.00
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,131 19,110 -10.03 614.87 -1,310,288 11,750,166
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4,000 21,241 23.20 52.03 208,120 1,105,169
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,197 17,241 -15.64 614.87 -1,965,739 10,600,974
2020-08-31 2020-08-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6,000 20,438 41.56 52.03 312,180 1,063,389
2020-05-15 2020-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,380 14,438 -36.73 572.00 -4,793,360 8,258,536
2020-05-15 2020-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -18,311 0 -100.00
2020-05-15 2020-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -9,931 22,818 -30.32 573.18 -5,692,251 13,078,821
2020-05-15 2020-05-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 18,311 32,749 126.83 59.20 1,084,011 1,938,741
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -577 14,438 -3.84 573.59 -330,961 8,281,492
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -61 15,015 -0.40 572.94 -34,949 8,602,694
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -112 15,076 -0.74 571.65 -64,025 8,618,195
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -125 15,188 -0.82 570.27 -71,284 8,661,261
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -234 15,313 -1.51 569.41 -133,242 8,719,375
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -669 15,547 -4.13 567.30 -379,524 8,819,813
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,000 18,311 -21.45
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -6,622 23,311 -22.12
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,000 29,933 -14.31
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,189 16,216 -6.83 566.44 -673,497 9,185,391
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,468 17,405 -7.78 565.60 -830,301 9,844,268
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -377 18,873 -1.96 564.74 -212,907 10,658,338
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -416 19,250 -2.12 563.58 -234,449 10,848,915
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -21 19,666 -0.11 562.71 -11,817 11,066,255
2020-04-20 2020-04-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -51 19,687 -0.26 561.57 -28,640 11,055,629
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2,720 19,738 -12.11 555.82 -1,511,830 10,970,775
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 22,458 28.64 59.20 296,000 1,329,514
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -3,602 17,458 -17.10 555.82 -2,002,064 9,703,506
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,622 21,060 45.87 59.20 392,022 1,246,752
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -94 14,438 -0.65 565.92 -53,196 8,170,753
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -93 14,532 -0.64 564.19 -52,470 8,198,809
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -171 14,625 -1.16 563.39 -96,340 8,239,579
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -191 14,796 -1.27 562.56 -107,449 8,323,638
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -63 14,987 -0.42 561.76 -35,391 8,419,097
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -163 15,050 -1.07 560.38 -91,342 8,433,719
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -285 15,213 -1.84 559.79 -159,540 8,516,085
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -293 15,498 -1.86 558.55 -163,655 8,656,408
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -93 15,791 -0.59 557.40 -51,838 8,801,903
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -198 15,884 -1.23 556.51 -110,189 8,839,605
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -114 16,082 -0.70 555.10 -63,281 8,927,118
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -104 16,196 -0.64 552.85 -57,496 8,953,959
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6 16,300 -0.04 550.00 -3,300 8,965,000
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 16,306 -0.61 549.24 -54,924 8,955,907
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -99 16,406 -0.60 548.27 -54,279 8,994,918
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 16,505 -0.60 547.00 -54,700 9,028,235
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5 16,605 -0.03 542.31 -2,712 9,005,058
2020-04-20 2020-04-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -95 16,610 -0.57 541.94 -51,484 9,001,623
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2,733 16,705 -14.06 529.79 -1,447,916 8,850,142
2020-04-20 2020-04-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 19,438 34.63 59.20 296,000 1,150,730
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6 14,438 -0.04 525.30 -3,152 7,584,281
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -106 14,444 -0.73 524.99 -55,649 7,582,956
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -113 14,550 -0.77 521.05 -58,879 7,581,278
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -220 14,663 -1.48 520.45 -114,499 7,631,358
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -286 14,883 -1.89 519.43 -148,557 7,730,677
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -499 15,169 -3.18 518.25 -258,607 7,861,334
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -266 15,668 -1.67 517.40 -137,628 8,106,623
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -260 15,934 -1.61 516.81 -134,371 8,234,851
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -414 16,194 -2.49 515.70 -213,500 8,351,246
2020-04-16 2020-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -92 16,608 -0.55 514.63 -47,346 8,546,975
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,000 34,933 -12.52
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2,738 16,700 -14.09 521.45 -1,427,730 8,708,215
2020-04-16 2020-04-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 19,438 34.63 59.20 296,000 1,150,730
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 14,438 -0.69 497.32 -49,732 7,180,306
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -210 14,538 -1.42 496.50 -104,265 7,218,117
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -321 14,748 -2.13 495.19 -158,956 7,303,062
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -111 15,069 -0.73 494.36 -54,874 7,449,511
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -652 15,180 -4.12 493.35 -321,664 7,489,053
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -521 15,832 -3.19 492.62 -256,655 7,799,160
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -450 16,353 -2.68 491.42 -221,139 8,036,191
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -484 16,803 -2.80 490.32 -237,315 8,238,847
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -734 17,287 -4.07 489.72 -359,454 8,465,790
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,626 18,021 -8.28 488.26 -793,911 8,798,933
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -470 19,647 -2.34 487.71 -229,224 9,582,038
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -485 20,117 -2.35 486.61 -236,006 9,789,133
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -441 20,602 -2.10 485.65 -214,172 10,005,361
2020-04-03 2020-04-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -192 21,043 -0.90 484.58 -93,039 10,197,017
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,000 39,933 -11.13
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,000 39,933 -11.13
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,000 44,933 -10.01
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2,689 21,235 -11.24 488.22 -1,312,824 10,367,352
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 23,924 26.42 59.20 296,000 1,416,301
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 23,924 26.42 59.20 296,000 1,416,301
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,000 23,924 26.42 59.20 296,000 1,416,301
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2,757 18,924 -12.72 488.22 -1,346,023 9,239,075
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -2,757 18,924 -12.72 488.22 -1,346,023 9,239,075
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 24,500 24,500
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2,625 14,438 22.22
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 20,000 20,000
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 23,337 23,337
2016-12-19 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 24,565 24,565
2016-09-02 2016-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes -4,943 11,813 -29.50 392.63 -1,940,770 4,638,138
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 28,900 28,900
2015-09-02 2015-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -1,689 0 -100.00
2015-09-02 2015-09-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1,689 16,756 11.21 59.20 99,989 991,955
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -3,097 1,689 -64.71
2015-03-26 2015-03-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 3,097 15,067 25.87 59.20 183,342 891,966
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -18,311 54,933 -25.00
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -1,970 4,786 -29.16
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 1,970 11,970 19.70 59.20 116,624 708,624
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -18,311 10,000 -64.68 450.00 -8,239,950 4,500,000
2015-03-17 2015-03-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 18,311 28,311 183.11 59.20 1,084,011 1,676,011
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 34,000 34,000
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 6,000 10,000 150.00
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 40,000 40,000
2012-12-17 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 50,000 50,000
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)